| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 15,995 | 22,009 | ||
| Selling, general and administrative | 10,397 | 10,345 | ||
| Total costs and expenses | 26,392 | 32,354 | ||
| Loss from operations | -26,392 | -32,354 | ||
| Interest expense, net of remeasurement adjustments and other | -13,355 | 15 | ||
| Interest and other income | 616 | 1,241 | ||
| Loss on early extinguishment of 2026 notes | 0 | -2,968 | ||
| Net loss on change in fair value of financial instruments | -8,822 | 8,207 | ||
| Net loss from continuing operations | -21,243 | -25,889 | ||
| Net loss | -30,917 | -25,424 | ||
| Us-gaap_earningspersharebasic | -0.47 | -0.43 | ||
| Us-gaap_earningspersharediluted | -0.47 | -0.43 | ||
| Weighted-average shares used to compute basic net income (loss) per share (in shares) | 66,263,992 | 58,585,083 | ||
OMEROS CORP (OMER)
OMEROS CORP (OMER)